{"result": {"id": "chatcmpl-834", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "**Lenvatinib** is a drug that inhibits receptor tyrosine kinases and acts as a multi-kinase inhibitor, achieving this by inhibiting angiogenesis, the process of forming new blood vessels. It is primarily used in treating cancer.  Specifically, it is classified as a fourth type of drug used for treating liver cancer. \n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743240929, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 66, "prompt_tokens": 206, "total_tokens": 272, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\n\n#######\n-Data-\nEntities: \"LENVATINIB\"\nDescription List: [\"**Lenvatinib** is a drug that inhibits receptor tyrosine kinases and acts as a multi-kinase inhibitor.  It achieves this by inhibiting angiogenesis, the process of forming new blood vessels. Lenvatinib is primarily used in treating cancer. \\n\", \"Fourth type of drug used for treating liver cancer\"]\n#######\nOutput:\n", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 500, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_summarize_240a2c7ce83a4e7e7ab437f413af275e1c716bb6679de2dcef82e09672c0286b_v2"}